Ocular Therapeutix To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting

Ocular Therapeutix announced multiple presentations at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting being held September 30-October 3, 2022 at McCormick Place Convention Center in Chicago.

“We have a big presence at AAO this year with many presentations discussing product candidates across multiple ophthalmic indications, with an emphasis on retina,” Rabia Gurses Ozden, MD, Chief Medical Officer of Ocular Therapeutix, said in a company news release. “Most notably, we anticipate presenting 28-week data from our U.S. phase 1 trial of OTX-TKI for the treatment of wet AMD in a late breaker session on Friday afternoon. We will also be making two ePoster presentations on the OTX-TKI program as well as sharing real-world data updates on Dextenza.”

Eyecelerator@AAO 2022 Retina Showcase Presentation:

• Session Title: Presenting Company Showcase: Retina, Therapeutics, and Technology + Devices
  Presentation Date/Times: Thursday, September 29, 2022, 2:00 – 2:05 PM CDT
  Location: McCormick Place Convention Center
  Presentation type: Podium Presentation
  Presenter: Peter K. Kaiser, MD

Retina Subspecialty Day Presentation:

• Title: Interim Safety and Efficacy Data from a Phase 1 Clinical Trial of Sustained-release Axitinib Hydrogel Implant (OTX-TKI) in Wet AMD Subjects
  Session Title: Late Breaking Developments, Part I (RET09)
  Presentation Date/Times: Friday, September 30, 2022, 3:29-3:34 PM CDT
  Location: Arie Crown
  Presentation type: Podium Presentation
  Presenter: Dilsher S. Dhoot, MD

Poster Theater Presentation:

• Title: Real-World Safety Analysis of an Intracanalicular Dexamethasone Insert Using the Academy's IRIS® Registry
  Session Title: Cataract (PT01)
  Presentation Date/Times: Saturday, October 1, 2022, 9:40-9:50 AM CDT
  Location: Hall A Poster Theater and Lounge
  Presentation type: Poster Theatre
  Presenter: Robert T. Chang, MD

ePosters:

• Title: Real-World Patient Demographics and Clinical Characteristics of an Intracanalicular Dexamethasone Insert Using the Academy’s IRIS® Registry
  Session Title: Cataract
  Viewing Date/Times: Tuesday, September 27, 2022 starting at 9:00 AM CDT
  Presentation type: ePoster (PO021)
  Presenter: Michael Mbagwu, MD

• Title: Interim 28-weeks Data from a Phase 1 US Study of Sustained-release Axitinib Hydrogel Implant (OTX-TKI) in Previously Treated Wet AMD Subjects
  Session Title: Retina, Vitreous
  Viewing Date/Times: Friday, September 30, 2022 starting at 5:00 PM CDT
  Presentation type: ePoster (PO359)
  Presenter: Arshad M. Khanani, MD

• Title: Australia-based Phase 1 Trial of a Novel, Hydrogel-based, Intravitreal Axitinib Implant for the Treatment of Neovascular Age-related Macular Degeneration
  Session Title: Retina, Vitreous
  Viewing Date/Times: Friday, September 30, 2022 starting at 5:00 PM CDT
  Presentation type: ePoster (PO360)
  Presenter: Andrew A. Moshfeghi, MD